Back to All Articles
You must be logged in to create a new articleBrowse articles with tag: Biosimilars
All Articles
The U.S. Supreme Court is About to Ultimately Decide Amgen vs Sanofi Antibody Patent Case
Most of the community involved in life science litigation and pharmaceutical companies, thought they saw the end of the long-fought... Read More
Patexia Insight 157: Most Active Companies in Biosimilar Litigation (BPCIA Act)
In late August, we published our third annual ANDA Litigation Intelligence Report. We evaluated the stakeholders for Hatch-Waxman cases filed... Read More
Patexia Insight 152: Best Performing Brand and Generic Pharmas of 2022 (ANDA)
Last month, we released our third annual ANDA Litigation Intelligence Report evaluating all stakeholders in ANDA/Hatch-Waxman cases filed over the... Read More
Patexia Insight 151: ANDA Litigators Who Moved in the Last 12 Months
In late August we released our third annual ANDA Litigation Intelligence Report. The report covered the ANDA litigation landscape by... Read More
Pfizer and BioNTech Strike Back to CureVac's Lawsuit by Seeking Declaratory Judgment of Noninfringement | Who Will Control mRNA Tech?
Two days ago, the companies that joined forces in order to develop the first Covid vaccine that got approval for... Read More
Pfizer and BioNTech Sued Again Over Covid Vaccine Technology, This Time by Moderna
Less than two months ago, Curevac filed a lawsuit in the German Regional Court in Düsseldorf against BioNTech over patent... Read More